Toufigh Gordi

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

Hsiao D. Lieu, John C. Shryock, Gregory O. von Mering et al. · Journal of Nuclear Cardiology · 2007 · 138 citations

Thrombosis, Cardiovascular Disease, Medicine +10

Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria*

Michael Ashton, Nguyen Duy Sy, Nguyễn Văn Hướng et al. · Clinical Pharmacology & Therapeutics · 1998 · 98 citations

A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first‐pass hepatic extraction

Toufigh Gordi, Rujia Xie, Nguyễn Văn Hướng et al. · British Journal of Clinical Pharmacology · 2005 · 97 citations · Full text

Simple solution to a common statistical problem: Interpreting multiple tests

Toufigh Gordi, Harry J. Khamis · Clinical Therapeutics · 2004 · 92 citations

Reliability, Engineering, Simple Solution +10

A Population Pharmacokinetic/Pharmacodynamic Analysis of Regadenoson, an Adenosine A2A-Receptor Agonist, in Healthy Male Volunteers

Toufigh Gordi, Paul Frohna, Hai-Ling Sun et al. · Clinical Pharmacokinetics · 2006 · 77 citations

Medicine, Healthy Male Volunteers, Physiology +6